Zoetis to Participate in the Credit Suisse Healthcare Conference Print
Business Wire
Friday, 06 October 2017 03:06
Oct. 6, 2017 12:30 UTC

Zoetis to Participate in the Credit Suisse Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse Healthcare Conference on Tuesday, Nov. 7, 2017, in Scottsdale, Ariz. Executive Vice President and Chief Financial Officer Glenn David, will represent the company and respond to questions from analysts. He is scheduled to present at 11:30 a.m. ET (8:30 a.m. MT).

Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and

people who raise and care for farm and

Error. Page cannot be displayed. Please contact your service provider for more details. (30)

companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.

Contacts

Zoetis Inc.
Media:
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investors:
Steve Frank, 1-973-822-7141 (o)
steve.frank@zoetis.com


Source: Zoetis Inc.




BiomedReports is not paid or compensated by newswires to disseminate or report news and
developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1